Plasma membrane monoamine transporters: structure, regulation and function

@article{Torres2003PlasmaMM,
  title={Plasma membrane monoamine transporters: structure, regulation and function},
  author={Gonzalo E. Torres and Raul R. Gainetdinov and Marc G. Caron},
  journal={Nature Reviews Neuroscience},
  year={2003},
  volume={4},
  pages={13-25}
}
The classical biogenic amine neurotransmitters — dopamine, noradrenaline, and 5-hydroxytryptamine — control a variety of functions including locomotion, autonomic function, hormone secretion, and the complex behaviours that are associated with affect, emotion and reward. A key step that determines the intensity and duration of monoamine signalling at synapses is the reuptake of the released transmitter into nerve terminals through high-affinity plasma membrane transporters. In recent years… 
Psychostimulants and monoamine transporters: upsetting the balance.
Kinase-dependent Regulation of Monoamine Neurotransmitter Transporters
TLDR
The discussion can lead to a more nuanced and integrated understanding of how neurotransmitter transporters are controlled and may contribute to disorders that feature perturbed monoamine signaling, with an ultimate goal of developing better therapeutic strategies.
Monoamine transporters: structure, intrinsic dynamics and allosteric regulation
TLDR
Recent progress in the elucidation of the structural dynamics of MATs and their conformational landscape and transitions, as well as allosteric regulation mechanisms are reviewed.
The neurochemical bases of the pharmacological activity of ligands of monoamine-transport systems
TLDR
The transport systems of the monoamines dopamine, noradrenaline, and serotonin are reviewed, which are localized in cytoplasmic membranes and the membranes of synaptic vesicles, and the structure of the transporters and the mechanisms of their functioning are presented.
Proteins interacting with monoamine transporters: current state and future challenges.
TLDR
The realization that monoamine transporters do not work alone opens the path to a plethora of possible pharmacological interventions.
The plasma membrane monoamine transporter (PMAT): Structure, function, and role in organic cation disposition
  • J. Wang
  • Chemistry, Biology
    Clinical pharmacology and therapeutics
  • 2016
TLDR
The latest understanding of PMAT is summarized and its roles in monoamine uptake and xenobiotic disposition are summarized.
Neurotransmitter transporters: why dance with so many partners?
Phosphorylation and Regulation of Psychostimulant-Sensitive Neurotransmitter Transporters
  • R. Vaughan
  • Biology, Psychology
    Journal of Pharmacology and Experimental Therapeutics
  • 2004
TLDR
Phosphorylation-mediated regulation of monoamine transporters provides the potential for acute presynaptic control of neurotransmitter levels during normal neurophysiologic events, and dysregulation of these processes may lead to inappropriate transmitter clearance that contributes to the etiology of neurological disorders.
Monoamine Transporter Pathologies
TLDR
This review considers the mechanism of transporter action and regulation of transporter function, the implications of transporter polymorphisms, and existing problems that need to be considered in future studies.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 195 REFERENCES
Localization and Dynamic Regulation of Biogenic Amine Transporters in the Mammalian Central Nervous System
TLDR
Information on the localization of mRNAs for these transporters in rodent and human brain is summarized along with immunohistochemical information at the light and electron microscopic levels, suggesting that monoamines may be released at these cellular domains.
Monoamine transporter pharmacology and mutant mice.
Monoamine transporters: from genes to behavior.
TLDR
Recent advances in understanding the physiology and pharmacology of monoamine transporters gained in mice with targeted genetic deletion of DAT, SERT, and NET are summarized.
From Genes to Behavior
TLDR
Recent advances in understanding the physiology and pharmacology of monoamine transporters gained in mice with targeted genetic deletion of DAT, SERT, and NET are summarized.
PET studies of brain monoamine transporters.
TLDR
The use of monoamine transporter ligands (or tracers) for imaging studies of cocaine dependence, neurodegenerative diseases and mechanism of antidepressant drug action is discussed, with special focus on the use of PET for evaluating possible new pharmacological innovations.
Dopamine transporters and neuronal injury.
The membrane‐bound rat serotonin transporter, SERT1, is an oligomeric protein
Phosphorylation and sequestration of serotonin transporters differentially modulated by psychostimulants.
TLDR
Findings reveal activity-dependent modulation of neurotransmitter reuptake and identify previously unknown consequences of amphetamine, cocaine, and antidepressant action.
Expression cloning of a cocaine-and antidepressant-sensitive human noradrenaline transporter
TLDR
A complementary DNA clone encoding a human noradrenaline transporter is isolated and the predicted protein sequence demonstrates significant amino-acid identity with the Na+/γ-aminobutyric acid transporter, thus identifying a new gene family for neurotransmitter transporter proteins.
...
1
2
3
4
5
...